China's GM Approval Process Could Cost Farmers Billions

The approval process of China for GM crops is affected by regulatory hurdles and delays that led to additional costs for US companies as well as added concern for farmers. According to researchers, some GM products have been waiting for approval for over six years, without any scientific basis for these prolonged delays. Thus, industry groups and some US policymakers have been proactive in pushing the Trump administration to press China to make more transparent and timely regulations for approval of GM crops.

Read more from CNBC and Informa/CropLife.


 

This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)

Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS

Article Search: